nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A7—Ifosfamide—testicular cancer	0.183	0.264	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.183	0.264	CbGbCtD
Eplerenone—CYP3A5—Ifosfamide—testicular cancer	0.137	0.198	CbGbCtD
Eplerenone—CYP3A5—Etoposide—testicular cancer	0.0655	0.0945	CbGbCtD
Eplerenone—CYP3A4—Ifosfamide—testicular cancer	0.0534	0.0771	CbGbCtD
Eplerenone—CYP3A4—Vinblastine—testicular cancer	0.0283	0.0409	CbGbCtD
Eplerenone—CYP3A4—Etoposide—testicular cancer	0.0255	0.0369	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—testicular cancer	0.0174	0.0251	CbGbCtD
Eplerenone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000472	0.00153	CcSEcCtD
Eplerenone—Discomfort—Etoposide—testicular cancer	0.00047	0.00153	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000468	0.00152	CcSEcCtD
Eplerenone—Hypotension—Cisplatin—testicular cancer	0.000465	0.00151	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000459	0.00149	CcSEcCtD
Eplerenone—Body temperature increased—Ifosfamide—testicular cancer	0.000456	0.00148	CcSEcCtD
Eplerenone—Abdominal pain—Ifosfamide—testicular cancer	0.000456	0.00148	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000453	0.00147	CcSEcCtD
Eplerenone—Infection—Etoposide—testicular cancer	0.000453	0.00147	CcSEcCtD
Eplerenone—Asthenia—Dactinomycin—testicular cancer	0.000452	0.00147	CcSEcCtD
Eplerenone—Blood creatinine increased—Doxorubicin—testicular cancer	0.000451	0.00146	CcSEcCtD
Eplerenone—Dehydration—Doxorubicin—testicular cancer	0.000447	0.00145	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000446	0.00145	CcSEcCtD
Eplerenone—Eosinophilia—Epirubicin—testicular cancer	0.000445	0.00145	CcSEcCtD
Eplerenone—Dyspnoea—Cisplatin—testicular cancer	0.000444	0.00144	CcSEcCtD
Eplerenone—Skin disorder—Etoposide—testicular cancer	0.000443	0.00144	CcSEcCtD
Eplerenone—Hyperhidrosis—Etoposide—testicular cancer	0.000441	0.00143	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000439	0.00143	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—testicular cancer	0.000438	0.00142	CcSEcCtD
Eplerenone—Angina pectoris—Epirubicin—testicular cancer	0.000438	0.00142	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000433	0.00141	CcSEcCtD
Eplerenone—Bronchitis—Epirubicin—testicular cancer	0.000432	0.0014	CcSEcCtD
Eplerenone—Diarrhoea—Dactinomycin—testicular cancer	0.000431	0.0014	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—testicular cancer	0.000431	0.0014	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00043	0.0014	CcSEcCtD
Eplerenone—Vomiting—Bleomycin—testicular cancer	0.000429	0.0014	CcSEcCtD
Eplerenone—Infestation—Methotrexate—testicular cancer	0.000428	0.00139	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—testicular cancer	0.000428	0.00139	CcSEcCtD
Eplerenone—Depression—Methotrexate—testicular cancer	0.000427	0.00139	CcSEcCtD
Eplerenone—Hypotension—Etoposide—testicular cancer	0.000426	0.00138	CcSEcCtD
Eplerenone—Rash—Bleomycin—testicular cancer	0.000426	0.00138	CcSEcCtD
Eplerenone—Pain—Cisplatin—testicular cancer	0.000426	0.00138	CcSEcCtD
Eplerenone—Dermatitis—Bleomycin—testicular cancer	0.000425	0.00138	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000424	0.00138	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—testicular cancer	0.000421	0.00137	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000418	0.00136	CcSEcCtD
Eplerenone—Asthenia—Ifosfamide—testicular cancer	0.000414	0.00135	CcSEcCtD
Eplerenone—Eosinophilia—Doxorubicin—testicular cancer	0.000412	0.00134	CcSEcCtD
Eplerenone—Feeling abnormal—Cisplatin—testicular cancer	0.00041	0.00133	CcSEcCtD
Eplerenone—Pruritus—Ifosfamide—testicular cancer	0.000408	0.00133	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—testicular cancer	0.000408	0.00133	CcSEcCtD
Eplerenone—Dyspnoea—Etoposide—testicular cancer	0.000406	0.00132	CcSEcCtD
Eplerenone—Hyperglycaemia—Epirubicin—testicular cancer	0.000405	0.00132	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—testicular cancer	0.000405	0.00132	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—testicular cancer	0.000405	0.00132	CcSEcCtD
Eplerenone—Pneumonia—Epirubicin—testicular cancer	0.000403	0.00131	CcSEcCtD
Eplerenone—Nausea—Bleomycin—testicular cancer	0.000401	0.0013	CcSEcCtD
Eplerenone—Infestation NOS—Epirubicin—testicular cancer	0.000401	0.0013	CcSEcCtD
Eplerenone—Infestation—Epirubicin—testicular cancer	0.000401	0.0013	CcSEcCtD
Eplerenone—Vomiting—Dactinomycin—testicular cancer	0.0004	0.0013	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—testicular cancer	0.0004	0.0013	CcSEcCtD
Eplerenone—Rash—Dactinomycin—testicular cancer	0.000397	0.00129	CcSEcCtD
Eplerenone—Diarrhoea—Ifosfamide—testicular cancer	0.000395	0.00128	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—testicular cancer	0.000394	0.00128	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000394	0.00128	CcSEcCtD
Eplerenone—Body temperature increased—Cisplatin—testicular cancer	0.000393	0.00128	CcSEcCtD
Eplerenone—Fatigue—Etoposide—testicular cancer	0.000393	0.00128	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000393	0.00128	CcSEcCtD
Eplerenone—Pain—Etoposide—testicular cancer	0.00039	0.00127	CcSEcCtD
Eplerenone—Constipation—Etoposide—testicular cancer	0.00039	0.00127	CcSEcCtD
Eplerenone—Urinary tract infection—Epirubicin—testicular cancer	0.000389	0.00127	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000386	0.00126	CcSEcCtD
Eplerenone—Haematuria—Epirubicin—testicular cancer	0.000382	0.00124	CcSEcCtD
Eplerenone—Dizziness—Ifosfamide—testicular cancer	0.000382	0.00124	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—testicular cancer	0.000381	0.00124	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—testicular cancer	0.00038	0.00123	CcSEcCtD
Eplerenone—Hepatobiliary disease—Epirubicin—testicular cancer	0.000379	0.00123	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—testicular cancer	0.000377	0.00122	CcSEcCtD
Eplerenone—Feeling abnormal—Etoposide—testicular cancer	0.000376	0.00122	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—testicular cancer	0.000375	0.00122	CcSEcCtD
Eplerenone—Nausea—Dactinomycin—testicular cancer	0.000374	0.00122	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—testicular cancer	0.000373	0.00121	CcSEcCtD
Eplerenone—Gastrointestinal pain—Etoposide—testicular cancer	0.000373	0.00121	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—testicular cancer	0.000371	0.0012	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—testicular cancer	0.000371	0.0012	CcSEcCtD
Eplerenone—Vomiting—Ifosfamide—testicular cancer	0.000367	0.00119	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—testicular cancer	0.000364	0.00118	CcSEcCtD
Eplerenone—Rash—Ifosfamide—testicular cancer	0.000364	0.00118	CcSEcCtD
Eplerenone—Dermatitis—Ifosfamide—testicular cancer	0.000364	0.00118	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000363	0.00118	CcSEcCtD
Eplerenone—Abdominal pain—Etoposide—testicular cancer	0.00036	0.00117	CcSEcCtD
Eplerenone—Body temperature increased—Etoposide—testicular cancer	0.00036	0.00117	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—testicular cancer	0.00036	0.00117	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—testicular cancer	0.000358	0.00116	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—testicular cancer	0.000358	0.00116	CcSEcCtD
Eplerenone—Asthenia—Cisplatin—testicular cancer	0.000357	0.00116	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—testicular cancer	0.000357	0.00116	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—testicular cancer	0.000357	0.00116	CcSEcCtD
Eplerenone—Urinary tract disorder—Epirubicin—testicular cancer	0.000355	0.00115	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—testicular cancer	0.000354	0.00115	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—testicular cancer	0.000353	0.00115	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—testicular cancer	0.000353	0.00115	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—testicular cancer	0.000353	0.00115	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000351	0.00114	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—testicular cancer	0.000349	0.00113	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—testicular cancer	0.000346	0.00113	CcSEcCtD
Eplerenone—Nausea—Ifosfamide—testicular cancer	0.000343	0.00111	CcSEcCtD
Eplerenone—Diarrhoea—Cisplatin—testicular cancer	0.00034	0.00111	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—testicular cancer	0.000337	0.00109	CcSEcCtD
Eplerenone—Tinnitus—Epirubicin—testicular cancer	0.000335	0.00109	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—testicular cancer	0.000335	0.00109	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—testicular cancer	0.000334	0.00108	CcSEcCtD
Eplerenone—Flushing—Epirubicin—testicular cancer	0.000334	0.00108	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—testicular cancer	0.000331	0.00108	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—testicular cancer	0.00033	0.00107	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—testicular cancer	0.000329	0.00107	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—testicular cancer	0.000328	0.00107	CcSEcCtD
Eplerenone—Asthenia—Etoposide—testicular cancer	0.000327	0.00106	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000327	0.00106	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—testicular cancer	0.000326	0.00106	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—testicular cancer	0.000326	0.00106	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—testicular cancer	0.000324	0.00105	CcSEcCtD
Eplerenone—Back pain—Methotrexate—testicular cancer	0.000324	0.00105	CcSEcCtD
Eplerenone—Pruritus—Etoposide—testicular cancer	0.000323	0.00105	CcSEcCtD
Eplerenone—Vomiting—Cisplatin—testicular cancer	0.000316	0.00103	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—testicular cancer	0.000315	0.00102	CcSEcCtD
Eplerenone—Rash—Cisplatin—testicular cancer	0.000314	0.00102	CcSEcCtD
Eplerenone—Dermatitis—Cisplatin—testicular cancer	0.000313	0.00102	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—testicular cancer	0.000313	0.00102	CcSEcCtD
Eplerenone—Diarrhoea—Etoposide—testicular cancer	0.000312	0.00101	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—testicular cancer	0.00031	0.00101	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—testicular cancer	0.00031	0.00101	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—testicular cancer	0.000309	0.001	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—testicular cancer	0.000309	0.001	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—testicular cancer	0.000309	0.001	CcSEcCtD
Eplerenone—Flatulence—Epirubicin—testicular cancer	0.000309	0.001	CcSEcCtD
Eplerenone—Back pain—Epirubicin—testicular cancer	0.000303	0.000984	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—testicular cancer	0.000302	0.000981	CcSEcCtD
Eplerenone—Malaise—Methotrexate—testicular cancer	0.000302	0.00098	CcSEcCtD
Eplerenone—Dizziness—Etoposide—testicular cancer	0.000301	0.00098	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—testicular cancer	0.000301	0.000978	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—testicular cancer	0.0003	0.000975	CcSEcCtD
Eplerenone—Nausea—Cisplatin—testicular cancer	0.000296	0.00096	CcSEcCtD
Eplerenone—Cough—Methotrexate—testicular cancer	0.000292	0.000949	CcSEcCtD
Eplerenone—Mental disorder—Doxorubicin—testicular cancer	0.000292	0.000947	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—testicular cancer	0.000291	0.000944	CcSEcCtD
Eplerenone—Vomiting—Etoposide—testicular cancer	0.00029	0.000942	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—testicular cancer	0.00029	0.000941	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—testicular cancer	0.000289	0.00094	CcSEcCtD
Eplerenone—Rash—Etoposide—testicular cancer	0.000287	0.000934	CcSEcCtD
Eplerenone—Dermatitis—Etoposide—testicular cancer	0.000287	0.000933	CcSEcCtD
Eplerenone—Headache—Etoposide—testicular cancer	0.000286	0.000928	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—testicular cancer	0.000285	0.000928	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—testicular cancer	0.000285	0.000926	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—testicular cancer	0.000285	0.000926	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—testicular cancer	0.000285	0.000926	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000283	0.000919	CcSEcCtD
Eplerenone—Malaise—Epirubicin—testicular cancer	0.000282	0.000917	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—testicular cancer	0.000281	0.000914	CcSEcCtD
Eplerenone—Syncope—Epirubicin—testicular cancer	0.000281	0.000912	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—testicular cancer	0.00028	0.000911	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—testicular cancer	0.000279	0.000905	CcSEcCtD
Eplerenone—Loss of consciousness—Epirubicin—testicular cancer	0.000275	0.000894	CcSEcCtD
Eplerenone—Cough—Epirubicin—testicular cancer	0.000273	0.000888	CcSEcCtD
Eplerenone—Infection—Methotrexate—testicular cancer	0.000271	0.000881	CcSEcCtD
Eplerenone—Nausea—Etoposide—testicular cancer	0.000271	0.00088	CcSEcCtD
Eplerenone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000269	0.000873	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—testicular cancer	0.000268	0.00087	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—testicular cancer	0.000268	0.00087	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—testicular cancer	0.000267	0.000866	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—testicular cancer	0.000267	0.000866	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—testicular cancer	0.000267	0.000866	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—testicular cancer	0.000265	0.000862	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000265	0.00086	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—testicular cancer	0.000264	0.000858	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—testicular cancer	0.000263	0.000856	CcSEcCtD
Eplerenone—Malaise—Doxorubicin—testicular cancer	0.000261	0.000849	CcSEcCtD
Eplerenone—Syncope—Doxorubicin—testicular cancer	0.00026	0.000844	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—testicular cancer	0.000255	0.000829	CcSEcCtD
Eplerenone—Loss of consciousness—Doxorubicin—testicular cancer	0.000255	0.000827	CcSEcCtD
Eplerenone—Infection—Epirubicin—testicular cancer	0.000254	0.000825	CcSEcCtD
Eplerenone—Cough—Doxorubicin—testicular cancer	0.000253	0.000821	CcSEcCtD
Eplerenone—Shock—Epirubicin—testicular cancer	0.000251	0.000817	CcSEcCtD
Eplerenone—Nervous system disorder—Epirubicin—testicular cancer	0.000251	0.000814	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000249	0.000808	CcSEcCtD
Eplerenone—Skin disorder—Epirubicin—testicular cancer	0.000248	0.000807	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—testicular cancer	0.000247	0.000803	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—testicular cancer	0.000247	0.000803	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—testicular cancer	0.000247	0.000801	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—testicular cancer	0.000247	0.000801	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—testicular cancer	0.000247	0.000801	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000245	0.000796	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—testicular cancer	0.000244	0.000792	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—testicular cancer	0.000243	0.000791	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—testicular cancer	0.00024	0.000781	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—testicular cancer	0.000239	0.000776	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000236	0.000766	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—testicular cancer	0.000235	0.000765	CcSEcCtD
Eplerenone—Infection—Doxorubicin—testicular cancer	0.000235	0.000763	CcSEcCtD
Eplerenone—Pain—Methotrexate—testicular cancer	0.000233	0.000759	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000233	0.000757	CcSEcCtD
Eplerenone—Shock—Doxorubicin—testicular cancer	0.000233	0.000756	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—testicular cancer	0.000232	0.000753	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—testicular cancer	0.000231	0.000751	CcSEcCtD
Eplerenone—Skin disorder—Doxorubicin—testicular cancer	0.00023	0.000746	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000229	0.000743	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—testicular cancer	0.000228	0.00074	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—testicular cancer	0.000225	0.000731	CcSEcCtD
Eplerenone—Dyspepsia—Epirubicin—testicular cancer	0.000225	0.000731	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000223	0.000726	CcSEcCtD
Eplerenone—Hypotension—Doxorubicin—testicular cancer	0.000221	0.000718	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000221	0.000717	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—testicular cancer	0.00022	0.000716	CcSEcCtD
Eplerenone—Pain—Epirubicin—testicular cancer	0.000219	0.00071	CcSEcCtD
Eplerenone—Constipation—Epirubicin—testicular cancer	0.000219	0.00071	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—testicular cancer	0.000216	0.000701	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—testicular cancer	0.000216	0.000701	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000215	0.0007	CcSEcCtD
Eplerenone—Insomnia—Doxorubicin—testicular cancer	0.000214	0.000695	CcSEcCtD
Eplerenone—Dyspnoea—Doxorubicin—testicular cancer	0.000211	0.000685	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—testicular cancer	0.000211	0.000684	CcSEcCtD
Eplerenone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000209	0.000679	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—testicular cancer	0.000208	0.000676	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000204	0.000663	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—testicular cancer	0.000204	0.000662	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—testicular cancer	0.000202	0.000657	CcSEcCtD
Eplerenone—Pain—Doxorubicin—testicular cancer	0.000202	0.000657	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—testicular cancer	0.000202	0.000656	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—testicular cancer	0.000202	0.000656	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—testicular cancer	0.000196	0.000637	CcSEcCtD
Eplerenone—Feeling abnormal—Doxorubicin—testicular cancer	0.000195	0.000633	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000193	0.000628	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—testicular cancer	0.000193	0.000628	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—testicular cancer	0.000187	0.000607	CcSEcCtD
Eplerenone—Body temperature increased—Doxorubicin—testicular cancer	0.000187	0.000607	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—testicular cancer	0.000187	0.000607	CcSEcCtD
Eplerenone—Asthenia—Epirubicin—testicular cancer	0.000183	0.000596	CcSEcCtD
Eplerenone—Pruritus—Epirubicin—testicular cancer	0.000181	0.000587	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—testicular cancer	0.000181	0.000587	CcSEcCtD
Eplerenone—Diarrhoea—Epirubicin—testicular cancer	0.000175	0.000568	CcSEcCtD
Eplerenone—Vomiting—Methotrexate—testicular cancer	0.000174	0.000564	CcSEcCtD
Eplerenone—Rash—Methotrexate—testicular cancer	0.000172	0.000559	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—testicular cancer	0.000172	0.000559	CcSEcCtD
Eplerenone—Headache—Methotrexate—testicular cancer	0.000171	0.000556	CcSEcCtD
Eplerenone—Asthenia—Doxorubicin—testicular cancer	0.00017	0.000551	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—testicular cancer	0.000169	0.000549	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—testicular cancer	0.000167	0.000544	CcSEcCtD
Eplerenone—Vomiting—Epirubicin—testicular cancer	0.000162	0.000528	CcSEcCtD
Eplerenone—Nausea—Methotrexate—testicular cancer	0.000162	0.000527	CcSEcCtD
Eplerenone—Diarrhoea—Doxorubicin—testicular cancer	0.000162	0.000526	CcSEcCtD
Eplerenone—Rash—Epirubicin—testicular cancer	0.000161	0.000524	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—testicular cancer	0.000161	0.000523	CcSEcCtD
Eplerenone—Headache—Epirubicin—testicular cancer	0.00016	0.00052	CcSEcCtD
Eplerenone—Dizziness—Doxorubicin—testicular cancer	0.000156	0.000508	CcSEcCtD
Eplerenone—Nausea—Epirubicin—testicular cancer	0.000152	0.000493	CcSEcCtD
Eplerenone—Vomiting—Doxorubicin—testicular cancer	0.00015	0.000488	CcSEcCtD
Eplerenone—Rash—Doxorubicin—testicular cancer	0.000149	0.000484	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—testicular cancer	0.000149	0.000484	CcSEcCtD
Eplerenone—Headache—Doxorubicin—testicular cancer	0.000148	0.000481	CcSEcCtD
Eplerenone—Nausea—Doxorubicin—testicular cancer	0.00014	0.000456	CcSEcCtD
